OpGen Technologies, Inc. Announces Formation of Public Health Consortium to Evaluate Whole Genome Mapping for Improved Genetic Analysis of Disease Outbreaks
Published: May 17, 2012
GAITHERSBURG, Md.--(BUSINESS WIRE)--OpGen, Inc., a commercial stage whole-genome analysis company, today announced the formation of a public health consortium to evaluate OpGen’s Whole Genome Mapping technology as an enhanced method for strain typing microorganisms that cause disease outbreaks. The consortium is comprised of the Association of Public Health Laboratories (APHL), the Centers for Disease Control and Prevention (CDC), the University of Maryland Institute for Genome Sciences, and 11 state public health laboratories from across the United States.